Napo Pharmaceuticals, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2001-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.napopharma.com
Clinical Trials
3
Trial Phases
3 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)
- Conditions
- Microvillus Inclusion DiseaseCongenital DisordersRare Diseases
- Interventions
- Drug: Placebo Powder for Oral Solution
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Napo Pharmaceuticals, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT06721871
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇮🇹UOS Gastroenterolgia e Riabilitazione nutrizionale Piazza Sant' Onofrio 4, Rome, Italy
🇦🇪Al Jalila Children's Hospital, Dubai, United Arab Emirates
Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy
- Conditions
- Cancer Therapy-Related DiarrheaChemotherapy-related DiarrheaProphylaxis of DiarrheaSymptomatic Relief of DiarrheaAdult Solid TumorTargeted Therapy-related Diarrhea
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-09-04
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Napo Pharmaceuticals, Inc.
- Target Recruit Count
- 287
- Registration Number
- NCT04538625
- Locations
- 🇺🇸
Arizona Oncology Associates PC - HAL, Prescott, Arizona, United States
🇺🇸Pacific Cancer Medical Center Inc, Anaheim, California, United States
🇺🇸The Oncology Institute of Hope and Innovation, Glendale, California, United States
Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea
- Conditions
- Human Immunodeficiency VirusHealthy VolunteersHIV/AIDSHIV DiarrheaAcquired Immunodeficiency Syndrome
- Interventions
- First Posted Date
- 2019-12-10
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- Napo Pharmaceuticals, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT04192487
- Locations
- 🇺🇸
Orange County Research Center, Tustin, California, United States
🇺🇸Healthcare Advocates International, Stratford, Connecticut, United States
🇺🇸The Research Institute, Springfield, Massachusetts, United States